Charles Schwab Investment Management Inc Angion Biomedica Corp. Transaction History

Charles Schwab Investment Management Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$1.1 - $2.23 $50,329 - $102,031	-45,754 Closed	0 $0
Q3 2021 Nov 16, 2021	BUY	$9.31 - $13.25 $116,784 - $166,208	12,544 Added 37.77%	45,754 $448,000
Q2 2021 Aug 16, 2021	SELL	$13.02 - $17.83 $20,936 - $28,670	-1,608 Reduced 4.62%	33,210 $433,000
Q1 2021 May 17, 2021	BUY	$15.01 - $25.74 $522,618 - $896,215	34,818 New	34,818 $630,000

Ticker ANGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 30,113,300
Description
Angion Biomedica Corp., a biopharmaceutical company, focuses on the discovery, development, and commercialization of small molecule therapeutics for acute organ injuries and fibrotic diseases. The company's lead product candidate is ANG-3070, an oral tyrosine kinase receptor inhibitor in development as a treatment for fibrotic diseases, primaril...

Get notified when there are updates to the investment portfolio of Charles Schwab Investment Management Inc, based on Form 13F filings with the SEC.

Stay updated on Charles Schwab Investment Management Inc with notifications on news.